Europe’s biggest biotech firm Actelion raised its full-year core-profit guidance after first-quarter earnings rose 25%.
WSJ.com: What's News US, Wall Street Journal
Mon, 04/20/2015 - 11:09pm
Europe’s biggest biotech firm Actelion raised its full-year core-profit guidance after first-quarter earnings rose 25%.